Methodological issues in pharmacokinetic-pharmacodynamic modelling

被引:41
|
作者
Bellissant, E
Sébille, V
Paintaud, G
机构
[1] Fac Med, Lab Pharmacol Expt & Clin, F-35043 Rennes, France
[2] Hop Brettoneau, Lab Pharmacol & Toxicol, Tours, France
关键词
D O I
10.2165/00003088-199835020-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article presents the theoretical and practical aspects involved in the design and analysis of pharmacokinetic-pharmacodynamic modelling studies. The main features of the protocol of pharmacokinetic-pharmacodynamic studies are discussed with special focus on experimental designs in relation to individual and population approaches. Some basic pharmacodynamic models (such as linear, log-linear, hyperbolic and sigmoid models) are presented as well as more complex time-dependent models (effect compartment and physiological indirect response, tolerance models) which are required when the concentration-effect relationship shows a hysteresis loop. The methods of estimation, with special focus on the individual and populations approaches, are covered, along with the way pharmacodynamic models and methods of estimation can be applied to real data and the information required to criticise the results of modelling. We also present some real problems frequently encountered when performing pharmacokinetic-pharmacodynamic modelling and give some potential solutions (problems with hysteresis loops, lack of convergence, problems with residuals). The last section discusses the significance of pharmacodynamic parameters.
引用
收藏
页码:151 / 166
页数:16
相关论文
共 50 条
  • [1] Methodological Issues in Pharmacokinetic-Pharmacodynamic Modelling
    Eric Bellissant
    Véronique Sébille
    Gilles Paintaud
    Clinical Pharmacokinetics, 1998, 35 : 151 - 166
  • [2] Pharmacokinetic-pharmacodynamic modelling in anaesthesia
    Gambus, Pedro L.
    Troconiz, Inaki F.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (01) : 72 - 84
  • [3] Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys
    Haritova, A. M.
    Rusenova, N. V.
    Parvanov, P. R.
    Lashev, L. D.
    Fink-Gremmels, J.
    VETERINARY RESEARCH COMMUNICATIONS, 2006, 30 (07) : 775 - 789
  • [4] Pharmacokinetic-pharmacodynamic modelling: History and perspectives
    Csajka, Chantal
    Verotta, Davide
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2006, 33 (03) : 227 - 279
  • [5] Pharmacokinetic-Pharmacodynamic Modelling of Danofloxacin in Turkeys
    A. M. Haritova
    N. V. Rusenova
    P. R. Parvanov
    L. D. Lashev
    J. Fink-Gremmels
    Veterinary Research Communications, 2006, 30 : 775 - 789
  • [6] Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling
    Colburn, WA
    Lee, JW
    CLINICAL PHARMACOKINETICS, 2003, 42 (12) : 997 - 1022
  • [7] Application of microdialysis for pharmacokinetic-pharmacodynamic modelling
    Hoecht, Christian
    Opezzo, Javier A. W.
    Bramuglia, Guillermo F.
    Taira, Carlos A.
    EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (04) : 289 - 301
  • [8] Pharmacokinetic-pharmacodynamic modelling of behavioural responses
    Della Paschoa, OE
    Kruk, MR
    Danhof, M
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1998, 23 (02): : 229 - 236
  • [9] Biomarkers, Validation and Pharmacokinetic-Pharmacodynamic Modelling
    Wayne A. Colburn
    Jean W. Lee
    Clinical Pharmacokinetics, 2003, 42 : 997 - 1022
  • [10] Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine
    Hoshen, MB
    Stein, WD
    Ginsburg, HD
    PARASITOLOGY, 2001, 123 : 337 - 346